Ama-Cytokines Nendlela Abasebenza ngayo

Izithunywa zeMolocular

Ama-Cytokines asebenza njengezithunywa zamangqamuzana phakathi kwamaseli. Ama-cytokines ama-proteine ​​akhiqizwa ngamaseli. Mayelana ne-arthritis, ama-cytokines alawula izimpendulo ezihlukahlukene zokuvuvukala . Ama-Cytokines asebenzisana namaseli omzimba omzimba ukuze aqondise impendulo yomzimba ezifweni nokutheleleka, kanye nokuxhumanisa izinqubo ezivamile zeselula emzimbeni.

Izinhlobo ze-Cytokines

Ama-Cytokines ahlukene, okusho ukuthi awafani ngokufanayo. Ama-Cytokines asebenza imisebenzi ehlukahlukene emzimbeni:

Ngenkathi "ama-cytokines" yisikhathi sesambulela esihlanganisa zonke izinhlobo, kunamagama akhethekile anikeziwe kuma-cytokines ngokususelwa kuhlobo lweseli olwenza noma isenzo abanalo emzimbeni:

Indlela ama-Cytokines asebenza ngayo

Amasosha omzimba ayinkimbinkimbi - izinhlobo ezahlukene zamasosha omzimba namaprotheni enza imisebenzi ehlukile. Ama-Cytokines aphakathi kwalawo maprotheni.

Ukuchaza ukuthi ama-cytokines asebenza kanjani kunzima. Kuyinto isifundo ku-physiology cell. Kodwa, ukuqonda ukuvuvukala, kufanele uqonde indima ama-cytokines adlala ngawo.

Ama-Cytokines akhululwa ngamaseli angena ekusakazweni noma ngokuqondile emathangeni. Ama-cytokines athola amangqamuzana omzimba omzimba futhi axhumane nama-receptors kumaseli okuvikela omzimba ngokuzibophezela.

Ukubambisana kubangela noma kuvuselela izimpendulo eziqondile ngamaseli ahlosiwe.

Ukukhiqizwa ngokweqile kwama-Cytokines

Ukukhiqizwa ngokweqile noma ukukhiqizwa okungalungile kwama-cytokines athile ngomzimba kungabangela izifo. Ngokwesibonelo, kutholakale ukuthi i-interleukin-1 (i-IL-1) ne- tumor necrosis factor-alpha (i-TNF-alpha) ikhiqizwa ngokweqile ku- arthritis ye-rheumatoid lapho ihileleka ekuvuvukala nasekubhujisweni kwezicubu.

Izidakamizwa ze-Biologic Ziyi-Cytokine Inhibitors

Izidakamizwa ze-biologic zenzelwe ukuvimbela IL-1 noma i-TNF-alpha. I-Kineret (anakinra) yasungulwa njengendlela yokwelapha isifo samathambo futhi isebenza ngokuvimbela ukubopha kwe-IL-1 kumamukeli wayo. I-TNF-alpha inhibitors (ebizwa nangokuthi i- TNF blockers ) ibopha i-TNF iphinde ivimbele i-TNF ukuthi ingahlanganiswa ne-cell surface receptors. Inbrel (etanercept), Remicade (infliximab), i- Humira (adalimumab), i-Simponi (golimumab), ne- Cimzia (certolizumab pegol) yi-block block ye-TNF. I-Actemra (tocilizumab) ibopha i-IL-6.

Izidakamizwa eziningi ze-biologic zisekuthuthukisweni. Ukutadisha kubangelwa isifundo seSigaba 3 sarilumab (okuthiwa i-SARIL-RA-TARGET), esiyi-antibody yomuntu ngokumelene ne-IL-6 receptor, sibonisa ukuthi lesi sidakamizwa sihlangene kokubili iziphetho eziyinhloko zokuthuthukiswa kwezibonakaliso nezimpawu zesifo samathambo kanye nokuthuthukiswa kwenyama umsebenzi.

I-Sarilumab ibopha ngokubambisana kakhulu ne-IL-6 receptor, ivimbela ukubopha kwe-IL-6 futhi iphazamise ukusayina kokuvuvukala kwe-cytokine-mediated. Kodwa-ke, ngo-Okthoba 31, 2016, i-FDA inqatshelwe i-sarilumab ngokususelwa ekuphutheni abayithole ngesikhathi sokuhlolwa kwenqubo yokukhiqiza. Uma kwenziwa ukulungiswa, i-Regeneron neSanofi ihlose ukuphinde ithumele ngokuvunywa ngo-2017. Phakathi naleso sikhathi, ngoFebhuwari 1, 2017, i-Health Canada yavuma isidakamizwa ngaphansi kwegama, uKezara (sarilumab).

Izwi elivela

Nakuba ama-cytokines abonakala njengento eyinkimbinkimbi, kubalulekile ukuqonda inqubo yokuvuvukala engumgogodla wezinhlobo zokuphefumula kwamathambo.

Siyazi ukuthi kukhona kokubili ama-cytokines ase-proinflammatory kanye nama-cytokines aphikisayo. I-cytokines ephazamisayo idlala indima ekuthuthukiseni ubuhlungu obuvuvukalayo kanye nobuhlungu be-neuropathic. I-cytokines elwa nokuvuvukala empeleni iyabhubhisa abaphikisi be-cytokine. Kunobufakazi bokuthi ama-chemokine ahilelekile ekuqaliseni ubuhlungu, kanye nasekuphikeleni ubuhlungu.

> Imithombo:

> Izinto zokukhula kanye nama-Cytokines. > Primer > kuma-Rheumatic Diseases. Edition 12. Ishicilelwe yi-Arthritis Foundation.

> I-Regeneron ne-Sanofi I-Current Results kusuka eSigaba Esiyinhloko Isifundo SakwaSarilumab eMhlanganweni Wonyaka We-American College of Rheumatology. Regeneron. Ngo-Novemba 8, 2015.

> McInnes I. no-Schett G. Cytokines ku-pathogenesis ye-arthritis ye-rheumatoid. Imvelo Immunology. Juni 2007

> Ama-Cytokines. BioBasics. 4/24/2006.

> Zhang, JM et al. Ama-Cytokines, Ukuvuvukala > no > Ubuhlungu. Imitholampilo yase-Anesthesiology International. Spring 2007.